From genes to outcomes: the prognostic role of genetic mutations in dilated cardiomyopathy

30 August 2025 (17:15 - 18:00)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Ines Miranda

Hospital Professor Doutor Fernando Fonseca, Amadora (Portugal)

6 More presentations in this session

Presentation thumbnail

Pre-transplant clinical and post-transplant outcomes of patients with a novel mutation in the emerin gene

Doctor M. Galvan Ruiz (Las Palmas de Gran Canaria, ES)

Abstract Slides Video

Presentation thumbnail

LMNA variants distribution and their impact on the cardiac phenotypic spectrum

Professor K. Pilichou (Padova, IT)

Abstract Slides Video

Presentation thumbnail

Refining genetic prediction in dilated cardiomyopathy: evaluating the Madrid Score and enhanced machine learning models with clinical and imaging data

Doctor I. Miranda (Amadora, PT)

Abstract Slides Video

Presentation thumbnail

Genotype-phenotype correlations with late gadolinium enhancement patterns in primary cardiomyopathy

Doctor M. Lima (Lisbon, PT)

Abstract Slides Video

Presentation thumbnail

Microstructural disease and hypoperfusion in dilated cardiomyopathy associate with ventricular arrhythmias and underpin midwall septal fibrosis

Doctor F. Chan (London, GB)

Abstract Slides

Access the full session

Session thumbnail

Precision medicine in dilated cardiomyopathy

The Event

Event poster

ESC Congress 2025

30 August 2025 17:15 CET

You may be interested in

Congress Presentation

Genotype-driven prognostication in dilated cardiomyopathy

Congress Presentation

Impact of genotype-phenotype associations on prognosis in dilated cardiomyopathy

Congress Presentation

The impact of genetic testing in dilated cardiomyopathy: are we yet in the era of precision medicine?

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources